MUC6 and hepatocellular carcinoma: To investigate the clinical impact of MUC6 on HCC progression, we used UALCAN and GEPIA 2 to assess the relationship between cellular levels of MUC6 of normal people and HCC patients and the overall survival of HCC patients.